Editas Medicine(DE:8EM)
€2.24-0.18 (-7.44%)
DE:8EM
Editas Medicine earnings date
€2.24
At close:-0.18 (-7.44%)
Editas Medicine (8EM) Q4 2022 Earnings Report
2 Followers
DE:8EM Q4 2022 EPS Results
- Actual EPS
- -EUR 0.80
- Consensus EPS
- -EUR 0.71
- Beat/Miss
- Missed by -EUR 0.08
- One Year Ago EPS
- -EUR 0.55
DE:8EM Q4 2022 Revenue Results
- Actual Revenue
- EUR 5.91M
- Expected Revenue
- EUR 3.31M
- Beat/Miss
- Beat by +EUR 2.60M
- YoY Revenue Growth
- -47.58%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/22/2023
- Time
- Before Open
- Conference Call
- Wednesday, February 22, 2023
DE:8EM Upcoming Earnings
Editas Medicine's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
DE:8EM Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8EM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.17- | -0.05 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.17-0.14 | -0.25 | 46.43% (+0.12) | |
| Aug 05, 2026 | 2026 (Q2) | -0.24-0.14 | -0.57 | 76.19% (+0.43) | |
| May 05, 2026 | 2026 (Q1) | -0.24-0.24 | -0.83 | 71.74% (+0.60) | |
| Mar 09, 2026 | 2025 (Q4) | -0.21-0.05 | -0.5 | 89.09% (+0.44) | |
| Nov 10, 2025 | 2025 (Q3) | -0.27-0.25 | -0.68 | 62.67% (+0.42) | |
| Aug 12, 2025 | 2025 (Q2) | -0.35-0.57 | -0.74 | 23.17% (+0.17) | |
| May 12, 2025 | 2025 (Q1) | -0.51-0.83 | -0.69 | -21.05% (-0.14) | |
| Mar 05, 2025 | 2024 (Q4) | -0.34-0.50 | -0.21 | -139.13% (-0.29) | |
| Nov 04, 2024 | 2024 (Q3) | -0.68-0.68 | -0.5 | -36.36% (-0.18) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
